ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,117.58
0.40%
Dow Jones
43,408.47
0.00%
Gold vs US Dollar
2,668.075
0.59%
Brent Oil
73.875
1.42%
Bitcoin
97,404.24
3.23%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Kura Oncology Inc (KURA) Share Price

KURA Kura Oncology Inc

11.75
-4.16 (-26.15%)
Pre Market
Last Updated: 14:09:11
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Kura Oncology Inc NASDAQ:KURA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -4.16 -26.15 11.75 11.72 11.78 0.00 0.00  354,124 14:09:11   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -152.63M -1.9628 -8.11 1.24B
 Type  Size  Price  Time  Units 
 9 60 11.75 14:10:22 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore KURA News
20/11/202422:21EDGAR2Form 8-K - Current report
20/11/202422:00PRNUSKura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
20/11/202422:00PRNUSKura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
20/11/202422:00GLOBEKura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
19/11/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
18/11/202421:03EDGAR2Form 144 - Report of proposed sale of securities
07/11/202421:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
30/11/200912:22PBBKurawood: A Hard Exterior with a Soft Centre78
Data Downloads for KURA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Kura Oncology Inc Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Level 2 Lite

1 year 40%, 2 years 50% and *3 years 60%
EU Flag

*Across 3 years £2132.64 only £853.06